Objective: Androgenetic alopecia is the commonest cause of hair loss in males and has been associated with coronary heart disease. This study aims to find relationship between androgenetic alopecia and metabolic syndrome. Materials and Methods: This hospital based case-control study was conducted on 50 clinically diagnosed male patients of early onset androgenetic alopecia (<30 years) with Norwood grade ≥ II. 50 age matched patients attending the outpatient department for other unrelated complaints were taken as controls. The patients were enquired regarding age, age of onset, occupation, family history of androgenetic alopecia and smoking habit. Examination for grade of disease, body mass index, blood pressure and waist circumference was done and patients investigated for hyperglycemia and dyslipidemia. Metabolic syndrome was diagnosed as per the National cholesterol education program's adult treatment panel III (NCEP ATP III) criteria. Results: Both the groups were statistically comparable in terms of age. Metabolic syndrome was found in 15 (30%) patients and 6 (12%) controls. 29 patients in case group and 16 in controls were dyslipidemic. Family history of androgenetic alopecia was found in 23 patients of case group and 12 patients of control group. However, we found no difference in increased blood pressure (>130/85) and hyperglycemia (FBS>100 mg/dL) between the two groups. Conclusion: Patients of early onset androgenetic alopecia appear to have greater frequency of metabolic syndrome especially dyslipidemia. Therefore, androgenetic alopecia patients may be evaluated for metabolic syndrome especially dyslipidemia.